Arima Genomics
Arima Genomics, Protean BioDiagnostics Launch 3D Genomics Cancer Testing Joint Venture
The new firm, Aventa Genomics, will offer through its Orlando lab a clinical next-generation sequencing test for gene fusions, translocations, and rearrangements.
Using Arima's technology, NYU researchers were able to identify a novel rearrangement in the PDL-1 gene in a pediatric brain tumor, which led to treatment with immunotherapy.